罗博特科(300757) - 2025 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2025 was ¥167,777,579.44, representing a decrease of 43.22% compared to the same period last year[5]. - The net profit attributable to shareholders was a loss of ¥41,418,725.58, a decline of 344.24% year-on-year[5]. - The company reported a basic earnings per share of -¥0.25, a decrease of 327.27% year-on-year[5]. - The company reported a net profit of -74,798,084.66 yuan, compared to a net profit of 71,136,709.17 yuan in the previous period, indicating a significant decline[30]. - Operating profit was -90,387,176.68 yuan, down from 75,571,471.25 yuan in the prior period, reflecting operational challenges[30]. - Total comprehensive income amounted to -75,796,292.64 yuan, compared to 70,590,276.75 yuan in the prior period, highlighting a substantial decrease[31]. - Basic and diluted earnings per share were both -0.47 yuan, down from 0.46 yuan in the previous period, indicating a loss per share[31]. Assets and Liabilities - The total assets at the end of the reporting period were ¥3,574,244,846.42, an increase of 51.11% from the end of the previous year[5]. - The equity attributable to shareholders increased by 65.26% to ¥1,665,145,166.03 compared to the previous year[5]. - The company's total liabilities reached ¥1,911,979,145.13, up from ¥1,360,345,431.87, representing an increase of about 40.5%[28]. - Non-current assets totaled ¥1,849,868,082.60, a significant rise from ¥792,463,927.83, indicating an increase of about 133%[27]. - Long-term borrowings surged by 751.57% to CNY 332,071,530.37, reflecting the borrowing for the major asset restructuring[10]. Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥55,985,445.35, an increase of 114.92%[5]. - Net cash flow from operating activities improved by 114.92% to CNY 55,985,445.35, primarily due to a decrease in payments to suppliers[13]. - The company experienced a significant increase in cash inflow from financing activities, totaling 1,689,633,398.30 yuan, compared to 859,234,993.59 yuan in the prior period[33]. - The company incurred a total investment cash outflow of 743,077,789.39 yuan, compared to 81,215,444.73 yuan in the previous period, indicating increased investment activity[33]. - Cash and cash equivalents at the end of the period totaled 353,078,442.44 yuan, an increase from 226,186,795.63 yuan at the end of the previous period[33]. Inventory and Expenses - The inventory increased by 113.50% to ¥438,045,308.09, primarily due to the completion of a significant asset restructuring[9]. - Operating costs fell by 59.60% to CNY 289,897,179.37 from CNY 717,570,320.65, reflecting the same cyclical industry challenges[12]. - Management expenses surged by 210.90% to CNY 74,651,854.99, mainly due to the consolidation of Feikong Technology following a major asset restructuring[12]. - Research and development expenses for the current period were ¥77,667,218.57, compared to ¥66,139,437.92 in the previous period, reflecting an increase of about 17.5%[29]. Shareholder Information - The company announced a cash dividend of 0.45 RMB per 10 shares, totaling 7,546,157.59 RMB distributed to shareholders[21]. - As of September 30, 2025, the total share capital was 167,692,391 shares, which was reduced to 167,608,111 shares after the repurchase and cancellation of 84,280 restricted stocks[24]. - The company’s major shareholders include Suzhou Yuanqiesheng Enterprise Management Consulting Co., Ltd., which is the controlling shareholder[16]. - The company’s major shareholders have engaged in margin financing, with specific details on shareholdings provided[16]. - The company plans to submit the adjusted profit distribution proposal as a temporary proposal for the 2024 annual shareholders' meeting[20]. Other Financial Metrics - The weighted average return on net assets was -2.76%, down 4.42% from the previous year[5]. - The company recognized a government subsidy of ¥2,069,833.87 during the reporting period, contributing to its financial performance[6]. - Investment income rose significantly by 542.76% to CNY 24,405,676.84, resulting from the revaluation of previously held equity in Feikong Technology[12]. - The company has not audited its third-quarter financial report, which may affect the reliability of the reported figures[34].